Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
OPERATING ACTIVITIES:
Net loss	$ (58,789)	$ (31,823)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	183	253
Provision for sales returns	134	78
Amortization of deferred financing cost and debt discounts	1,218	667
Stock-based compensation	34,681	619
Allowance for doubtful accounts	35
Other	59	90
Loss on early extinguishment on Midcap term loan		97
Changes in assets and liabilities:
Accounts receivable	309	(70)
Inventory	(5,360)	(9,974)
Prepaid and other current assets	(1,004)	(1,153)
Accounts payable, accrued and other liabilities	3,334	10,871
Cash used in operating activities	(25,200)	(30,345)
INVESTING ACTIVITIES:
Purchase of fixed assets	(114)	(61)
Cash consideration for acquisition of Aussie Health	(1,176)
Proceeds on sale of fixed assets	6	35
Cash used in investing activities	(1,284)	(26)
FINANCING ACTIVITIES:
Proceeds from Initial Public Offering	36,000
Borrowings from Mid Cap credit facility	98,663	62,665
Repayments from Mid Cap credit facility	(92,165)	(50,784)
Insurance financing proceeds	3,833
Insurance obligation payments	(2,783)
Capital lease obligation payments	(55)	(54)
Capital lease financing proceeds		20
Proceeds from exercise of stock options		18
Repayments from MidCap term loan		(6,776)
Prepayment penalty incurred with the Midcap term loan extinguishment		(97)
Deferred offering costs		(947)
Cash provided by financing activities	36,566	45,293
EFFECT OF EXCHANGE RATE ON CASH	(1)	(11)
NET CHANGE IN CASH AND RESTRICTED CASH FOR THE YEAR	10,081	14,911
CASH AND RESTRICTED CASH AT BEGINNING OF YEAR	20,708	5,797
CASH AND RESTRICTED CASH AT END OF YEAR	30,789	20,708
RECONCILIATION OF CASH AND RESTRICTED CASH
CASH	30,353	20,029
RESTRICTED CASH—Prepaid and other current assets	307	550
RESTRICTED CASH—Other non-current assets	129	129
CASH AND RESTRICTED CASH AT END OF YEAR	30,789	20,708
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest	3,201	1,555
Cash paid for taxes	21	3
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Equity fundraising costs not paid	160
Debt issuance costs not paid		1,388
Discount of debt relating to warrants issuance		929
Capital lease		25
Notes payable on acquisition	195
Initial Public Offering
FINANCING ACTIVITIES:
Issuance costs of stock	(5,446)
Series C Preferred Stock
FINANCING ACTIVITIES:
Issuance costs of stock		(2,997)
Proceeds from issuance of preferred stock - converted to common stock		23,969
Series C-1 Preferred Stock
FINANCING ACTIVITIES:
Issuance costs of stock		(1,243)
Proceeds from issuance of preferred stock - converted to common stock		7,660
Horizon Term Loan
FINANCING ACTIVITIES:
Debt issuance costs	(900)	(215)
Borrowings from term loan		15,000
Mid Cap Credit Facility
FINANCING ACTIVITIES:
Debt issuance costs	$ (581)	$ (926)